Retirement Planning Co of New England Inc. decreased its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 0.9% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 9,633 shares of the company’s stock after selling 88 shares during the period. Procter & Gamble makes up approximately 0.9% of Retirement Planning Co of New England Inc.’s investment portfolio, making the stock its 28th largest holding. Retirement Planning Co of New England Inc.’s holdings in Procter & Gamble were worth $1,432,000 as of its most recent SEC filing.
A number of other large investors have also modified their holdings of PG. EWG Elevate Inc. purchased a new stake in Procter & Gamble in the fourth quarter valued at approximately $26,000. Silicon Valley Capital Partners purchased a new stake in Procter & Gamble in the fourth quarter valued at approximately $28,000. Legend Financial Advisors Inc. purchased a new stake in Procter & Gamble in the third quarter valued at approximately $30,000. Luken Investment Analytics LLC purchased a new stake in Procter & Gamble in the fourth quarter valued at approximately $37,000. Finally, Bourgeon Capital Management LLC lifted its holdings in Procter & Gamble by 39.9% in the fourth quarter. Bourgeon Capital Management LLC now owns 249 shares of the company’s stock valued at $38,000 after acquiring an additional 71 shares during the period. Hedge funds and other institutional investors own 64.65% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft boosted their price target on Procter & Gamble from $160.00 to $170.00 and gave the company a “buy” rating in a report on Monday, April 24th. Royal Bank of Canada boosted their price target on Procter & Gamble from $160.00 to $165.00 and gave the company a “sector perform” rating in a report on Monday, April 24th. Evercore ISI boosted their price target on Procter & Gamble from $160.00 to $170.00 and gave the company an “outperform” rating in a report on Monday, April 24th. Morgan Stanley boosted their price target on Procter & Gamble from $160.00 to $174.00 and gave the company an “overweight” rating in a report on Monday, April 24th. Finally, Truist Financial downgraded Procter & Gamble from a “buy” rating to a “hold” rating and decreased their price target for the company from $165.00 to $155.00 in a report on Thursday, May 18th. Five investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $161.50.
Procter & Gamble Stock Down 2.1 %
Procter & Gamble (NYSE:PG – Free Report) last posted its quarterly earnings data on Friday, April 21st. The company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.32 by $0.05. Procter & Gamble had a return on equity of 32.18% and a net margin of 17.69%. The firm had revenue of $20.07 billion during the quarter, compared to the consensus estimate of $19.32 billion. During the same period in the prior year, the company earned $1.33 EPS. The firm’s revenue was up 3.5% compared to the same quarter last year. Research analysts anticipate that The Procter & Gamble Company will post 5.86 EPS for the current fiscal year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, May 15th. Shareholders of record on Friday, April 21st were issued a $0.9407 dividend. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.91. This represents a $3.76 annualized dividend and a yield of 2.53%. The ex-dividend date was Thursday, April 20th. Procter & Gamble’s dividend payout ratio is presently 65.51%.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 8,000 shares of the company’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $156.84, for a total value of $1,254,720.00. Following the completion of the sale, the chief executive officer now directly owns 9,343 shares in the company, valued at approximately $1,465,356.12. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 8,000 shares of the company’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $156.84, for a total value of $1,254,720.00. Following the completion of the sale, the chief executive officer now directly owns 9,343 shares in the company, valued at approximately $1,465,356.12. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Balaji Purushothaman sold 12,300 shares of the company’s stock in a transaction on Monday, April 24th. The shares were sold at an average price of $156.33, for a total value of $1,922,859.00. Following the completion of the sale, the insider now owns 13,001 shares of the company’s stock, valued at $2,032,446.33. The disclosure for this sale can be found here. Insiders sold a total of 95,093 shares of company stock worth $14,821,930 in the last three months. 0.26% of the stock is owned by corporate insiders.
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- MarketBeat Week in Review – 7/3 – 7/7
- Pfizer Just Invested $25 million In This Biotech
- Cracks In The Labor Market? Not Yet, But They’re Coming
- Levi’s: Buy On The Dip Or Downtrend In Play?
- Who Wins And Who Loses With China’s Metal Restrictions
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
